Application of PLGA in Tumor Immunotherapy
Open Access
Abstract
Biodegradable polymers have been extensively researched in the field of biomedicine. Polylactic-co-glycolic acid (PLGA), a biodegradable polymer material, has been widely used in drug delivery systems and has shown great potential in various medical fields, including vaccines, tissue engineering such as bone regeneration and wound healing, and 3D printing. Cancer, a group of diseases with high mortality rates worldwide, has recently garnered significant attention in the field of immune therapy research. In recent years, there has been growing interest in the delivery function of PLGA in tumor immunotherapy. In tumor immunotherapy, PLGA can serve as a carrier to load antigens on its surface, thereby enhancing the immune system’s ability to attack tumor cells. Additionally, PLGA can be used to formulate tumor vaccines and immunoadjuvants, thereby enhancing the efficacy of tumor immunotherapy. PLGA nanoparticles (NPs) can also enhance the effectiveness of tumor immunotherapy by regulating the activity and differentiation of immune cells, and by improving the expression and presentation of tumor antigens. Furthermore, due to the diverse physical properties and surface modifications of PLGA, it has a wider range of potential applications in tumor immunotherapy through the loading of various types of drugs or other innovative substances. We aim to highlight the recent advances and challenges of plga in the field of oncology therapy to stimulate further research and development of innovative PLGA-based approaches, and more effective and personalized cancer therapies.Keywords
Funding Information
- National Key R&D Program of China: BTIT (2022YFF1202803, JYTMS 20230133, LNYJG2023215)
- General Research Project of Liaoning Provincial Department of Education (2022YFF1202803, JYTMS 20230133, LNYJG2023215)
- Research Project of Liaoning Educational Committee (2022YFF1202803, JYTMS 20230133, LNYJG2023215)
This publication has 115 references indexed in Scilit:
- Immunized Microspheres Engineered Hydrogel Membrane for Reprogramming Macrophage and Mucosal RepairSmall, 2023
- Versatile Nano‐PROTAC‐Induced Epigenetic Reader Degradation for Efficient Lung Cancer TherapyAdvanced Science, 2022
- Recent advancements in single dose slow‐release devices for prophylactic vaccinesWIREs Nanomedicine and Nanobiotechnology, 2022
- In vitro and in vivo evaluation of DC-targeting PLGA nanoparticles encapsulating heparanase CD4+ and CD8+ T-cell epitopes for cancer immunotherapyCancer Immunology, Immunotherapy, 2022
- PLGA's Plight and the Role of Stealth Surface Modification Strategies in Its Use for Intravenous Particulate Drug DeliveryAdvanced Healthcare Materials, 2022
- Nanoparticle‐Enhanced Radiotherapy to Trigger Robust Cancer ImmunotherapyAdvanced Materials, 2019
- Biomineralization improves mechanical and osteogenic properties of multilayer‐modified PLGA porous scaffoldsJournal of Biomedical Materials Research Part A, 2018
- More Effective Nanomedicines through Particle DesignSmall, 2011
- Surface modification of poly(D,L‐lactic‐co‐glycolic acid) nanoparticles with protamine enhanced cross‐presentation of encapsulated ovalbumin by bone marrow‐derived dendritic cellsJournal of Biomedical Materials Research Part A, 2010
- Particle Shape: A New Design Parameter for Passive Targeting In Splenotropic Drug DeliveryJournal of Pharmaceutical Sciences, 2010